MRC vs. NWH.UN, CRR.UN, CRT.UN, DRM, WFC, AX.UN, MEQ, SGR.UN, MI.UN, and IIP.UN
Should you be buying Morguard stock or one of its competitors? The main competitors of Morguard include NorthWest Health Prop Real Est Inv Trust (NWH.UN), Crombie Real Estate Investment Trust (CRR.UN), CT Real Estate Investment Trust (CRT.UN), Dream Unlimited (DRM), Wall Financial (WFC), Artis Real Estate Investment Trust Unit (AX.UN), Mainstreet Equity (MEQ), Slate Grocery REIT (SGR.UN), Minto Apartment Real Estate Invt Trust (MI.UN), and Interrent Real Estate Investment Trust (IIP.UN). These companies are all part of the "real estate" sector.
Morguard (TSE:MRC) and NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) are both small-cap real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, dividends, community ranking, valuation, earnings and risk.
Morguard pays an annual dividend of C$0.60 per share and has a dividend yield of 0.5%. NorthWest Health Prop Real Est Inv Trust pays an annual dividend of C$0.36 per share and has a dividend yield of 7.4%. Morguard pays out 8.8% of its earnings in the form of a dividend. NorthWest Health Prop Real Est Inv Trust pays out -25.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. NorthWest Health Prop Real Est Inv Trust is clearly the better dividend stock, given its higher yield and lower payout ratio.
Morguard has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, NorthWest Health Prop Real Est Inv Trust has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.
Morguard has higher revenue and earnings than NorthWest Health Prop Real Est Inv Trust. NorthWest Health Prop Real Est Inv Trust is trading at a lower price-to-earnings ratio than Morguard, indicating that it is currently the more affordable of the two stocks.
3.2% of Morguard shares are held by institutional investors. Comparatively, 23.5% of NorthWest Health Prop Real Est Inv Trust shares are held by institutional investors. 72.7% of Morguard shares are held by company insiders. Comparatively, 0.3% of NorthWest Health Prop Real Est Inv Trust shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Morguard has a net margin of 5.97% compared to NorthWest Health Prop Real Est Inv Trust's net margin of -67.73%. Morguard's return on equity of 1.33% beat NorthWest Health Prop Real Est Inv Trust's return on equity.
In the previous week, NorthWest Health Prop Real Est Inv Trust had 1 more articles in the media than Morguard. MarketBeat recorded 1 mentions for NorthWest Health Prop Real Est Inv Trust and 0 mentions for Morguard. NorthWest Health Prop Real Est Inv Trust's average media sentiment score of 1.75 beat Morguard's score of 0.00 indicating that NorthWest Health Prop Real Est Inv Trust is being referred to more favorably in the news media.
Morguard presently has a consensus price target of C$135.00, indicating a potential upside of 22.17%. NorthWest Health Prop Real Est Inv Trust has a consensus price target of C$6.29, indicating a potential upside of 28.54%. Given NorthWest Health Prop Real Est Inv Trust's stronger consensus rating and higher probable upside, analysts plainly believe NorthWest Health Prop Real Est Inv Trust is more favorable than Morguard.
Morguard received 34 more outperform votes than NorthWest Health Prop Real Est Inv Trust when rated by MarketBeat users. Likewise, 69.12% of users gave Morguard an outperform vote while only 34.12% of users gave NorthWest Health Prop Real Est Inv Trust an outperform vote.
Summary
Morguard beats NorthWest Health Prop Real Est Inv Trust on 11 of the 20 factors compared between the two stocks.
Get Morguard News Delivered to You Automatically
Sign up to receive the latest news and ratings for MRC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Morguard Competitors List
Related Companies and Tools